| abstract |
The present invention relates to compounds for down-regulation of the RhoA gene, pharmaceutical compositions comprising the same, methods of use and kits thereof. The compounds, compositions, methods and kits are useful for conferring neuroprotection and in the treatment of a subject suffering from a disease or condition in which RhoA expression has adverse consequences and / or a syndrome associated with these diseases and conditions. |